These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35531461)

  • 21. Rapid development of band keratopathy of corneal graft associated with treatment with intracameral recombinant tissue plasminogen activator for postoperative fibrin reaction.
    Spitzer MS; Szurman P; Aisenbrey S; Rohrbach JM
    Eur J Ophthalmol; 2007; 17(3):433-6. PubMed ID: 17534830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of retinal arterial occlusion with local fibrinolysis using recombinant tissue plasminogen activator.
    Richard G; Lerche RC; Knospe V; Zeumer H
    Ophthalmology; 1999 Apr; 106(4):768-73. PubMed ID: 10201601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The use of tissue plasminogen activator in the post-operative treatment of fibrinoid uveitis].
    Chiseliţă D; Antohi I; Cionca D; Medvichi R; Cimpoeşu D
    Oftalmologia; 2006; 50(2):68-72. PubMed ID: 16927762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of postcataract fibrinous membranes with tissue plasminogen activator.
    Moon J; Chung S; Myong Y; Chung S; Park C; Baek N; Rhee S
    Ophthalmology; 1992 Aug; 99(8):1256-9. PubMed ID: 1513579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of anterior chamber fibrin following cataract surgery with tissue plasminogen activator.
    Lesser GR; Osher RH; Whipple D; Abrams GW; Cionni RJ
    J Cataract Refract Surg; 1993 Mar; 19(2):301-5. PubMed ID: 8487179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-dose tissue plasminogen activator in the management of anterior chamber fibrin formation.
    Georgiadis N; Boboridis K; Halvatzis N; Ziakas N; Moschou V
    J Cataract Refract Surg; 2003 Apr; 29(4):729-32. PubMed ID: 12686240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant tissue plasminogen activator (r-TPA) in fibrin dissolution due to postoperative endophthalmitis.
    Riaz Y; Mehta JS; Fernando A; Ferguson V
    Ann Acad Med Singap; 2006 Oct; 35(10):723-5. PubMed ID: 17102897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of recombinant tissue plasminogen activator for treatment of recalcitrant anterior uveitis: A case series.
    Patrick S; Hui-Tze C; Wan-Hazabbah WH; Zunaina E; Azhany Y; Liza-Sharmini AT
    J Taibah Univ Med Sci; 2018 Oct; 13(5):483-487. PubMed ID: 31435366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of intraocular fibrin formation with tissue plasminogen activator after vitrectomy].
    Zhao P; Wang W
    Zhonghua Yan Ke Za Zhi; 1995 Jul; 31(4):255-8. PubMed ID: 8745515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Anticoagulant and fibrinolytic therapies for anterior chamber fibrin following cataract surgery in the rabbit eye].
    Kimura M; Eguchi S; Araie M; Akahoshi T; Kohda F
    Nippon Ganka Gakkai Zasshi; 1992 Oct; 96(10):1240-7. PubMed ID: 1442347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term change in intraocular pressure after extracapsular cataract extraction with posterior chamber intraocular lens implantation versus phacoemulsification with posterior chamber intraocular lens implantation in Indians.
    Pal VK; Agrawal A; Suman S; Pratap VB
    Middle East Afr J Ophthalmol; 2013; 20(4):332-5. PubMed ID: 24339684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant tissue plasminogen activator following paediatric cataract surgery.
    Mehta JS; Adams GG
    Br J Ophthalmol; 2000 Sep; 84(9):983-6. PubMed ID: 10966949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of tissue plasminogen activator to revive blebs following intraocular surgery.
    Smith MF; Doyle JW
    Arch Ophthalmol; 2001 Jun; 119(6):809-12. PubMed ID: 11405830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of postvitrectomy fibrin pupillary block with tissue plasminogen activator.
    Jaffe GJ; Lewis H; Han DP; Williams GA; Abrams GW
    Am J Ophthalmol; 1989 Aug; 108(2):170-5. PubMed ID: 2502924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical use of recombinant tissue plasminogen activator for anterior chamber fibrinolysis.
    Lin CP
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1994 Jun; 10(6):332-6. PubMed ID: 8057416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasmin-mediated fibrinolysis by variant recombinant tissue plasminogen activators.
    Urano S; Metzger AR; Castellino FJ
    Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2568-71. PubMed ID: 2523073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of anterior segment fibrinous reactions and hemorrhage with intracameral low dose rt-PA: clinical study and review of the literature].
    Le Rouic JF; Behar-Cohen F; Nghiem MH; Renard G; Chauvaud D
    J Fr Ophtalmol; 2000 Dec; 23(10):977-83. PubMed ID: 11139689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of Anterior Segment OCT in the Management of Uveitic Cataract Surgery: A Fibrinoid Syndrome Case Treated with rtPA.
    Muñoz-Solano J; Tondini G; Zicarelli F; Staurenghi G; Oldani M; Invernizzi A
    Ocul Immunol Inflamm; 2023 May; ():1-4. PubMed ID: 37140351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous thrombolysis with recombinant staphylokinase versus tissue-type plasminogen activator in a rabbit embolic stroke model.
    Vanderschueren S; Van Vlaenderen I; Collen D
    Stroke; 1997 Sep; 28(9):1783-8. PubMed ID: 9303026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of Intracameral Tissue Plasminogen Activator During Uveitic Cataract Surgery.
    Hu WF; Etheridge T; Larochelle MB
    Ocul Immunol Inflamm; 2024 Jul; 32(5):673-677. PubMed ID: 37079881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.